Bio-Rad Laboratories A's 15min chart: KDJ Golden Cross triggers bullish Marubozu signal.

Bio-Rad Laboratories A's 15-minute chart has recently triggered a Golden Cross in the KDJ indicator, accompanied by a Bullish Marubozu at 08/11/2022 14:00. This suggests a shift in the momentum of the stock price towards the upside, potentially leading to further increases. The market appears to be under the control of buyers, and it is likely that the bullish momentum will continue.

Bio-Rad Laboratories Inc. (Bio-Rad) has recently experienced a significant technical indicator shift, with its 15-minute chart triggering a Golden Cross in the KDJ indicator, accompanied by a Bullish Marubozu at 08/11/2022 14:00. This development suggests a shift in the momentum of the stock price towards the upside, potentially leading to further increases. The market appears to be under the control of buyers, and it is likely that the bullish momentum will continue.

The KDJ Golden Cross is a technical indicator that signals a potential reversal in price trends when the K-line crosses above the J-line. This bullish signal is often accompanied by strong buying pressure, as indicated by the absence of wicks on the candles, forming a Bullish Marubozu pattern. The combination of these indicators suggests that Bio-Rad's stock price may continue to rise, with buyers dominating the market [1].

Investors should closely monitor Bio-Rad's financial announcements and earnings reports to assess the company's performance and potential impact on the stock price. Bio-Rad's second-quarter 2025 earnings report showed positive results, with revenue exceeding analyst estimates by 6.2% and earnings per share (EPS) surpassing estimates by 17%. Looking ahead, revenue is forecast to grow 7.2% per annum on average during the next three years, compared to a 5.1% growth forecast for the Metals and Mining industry in the US [2].

Institutional investors have also expressed confidence in Bio-Rad. The company recently declared a third-quarter 2025 dividend of $0.14 per share, payable on September 5, 2025 [3]. Bio-Rad's strong financial performance and positive analyst sentiment suggest that the stock is well-positioned for continued bullish momentum in the near future.

References:
[1] https://www.ainvest.com/news/materion-15-minute-chart-displays-kdj-golden-cross-bullish-marubozu-2508/
[2] https://www.htfmarketintelligence.com/sample-report/global-protein-purification-and-isolation-market?utm_source=Alefiya_NewsTrail&utm_id=Alefiya
[3] https://www.newstrail.com/protein-purification-and-isolation-market-may-see-big-move-merck-millipore-qiagen-n-v-promega-corporation/